Home › NDC Lookup › RxCUI directory › RxCUI 1738806

24 HR paroxetine hydrochloride 25 MG Extended Release Oral Tablet [Paxil] — RxCUI 1738806

RxNorm drug concept · Semantic branded drug
RxCUI 1738806 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1738806
Official name24 HR paroxetine hydrochloride 25 MG Extended Release Oral Tablet [Paxil]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Paxil 25 MG Extended Release Oral Tablet; PAXIL CR 25 MG 24HR Extended Release Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)50 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Paroxetine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It usually takes a few weeks before you notice the full benefit — that's completely normal for this type of medication. Some people notice small improvements in sleep or energy wit...
  • How long before I start feeling better on paroxetine?
  • Please don't stop suddenly — paroxetine is one of the antidepressants most likely to cause discontinuation symptoms if you quit cold turkey. These can include dizziness, nausea, ir...
  • Can I just stop taking paroxetine if I feel better or if it bothers me?
📖 Read our full Paroxetine guide →

🕸️ Concept Web — How 24 HR paroxetine hydrochloride 25 MG Extended Re... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR paroxetine hydrochloride 25 MG Extended Release Oral Tablet [Paxil] RxCUI 1738806

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Paroxetine 32937
    • Paroxetine hydrochloride 235830
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Paxil 114228
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Paroxetine Extended Release Oral Tablet 562789
    • Paroxetine hydrochloride Extended Release Oral Tablet 2648574
    • Paroxetine Oral Product 1164137
    • Paroxetine Pill 1164138
    • Paroxetine hydrochloride Oral Product 2662815
    • Paroxetine hydrochloride Pill 2663638
    • Paroxetine Extended Release Oral Tablet [Paxil] 828445
    • Paroxetine hydrochloride Extended Release Oral Tablet [Paxil] 2657455
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 24 HR paroxetine hydrochloride 25 MG Extended Release Oral Tablet SCD · 1738805
  • Paroxetine hydrochloride 25 MG SCDC · 1738498
  • Paroxetine Extended Release Oral Tablet SCDF · 562789
  • Paroxetine hydrochloride Extended Release Oral Tablet SCDFP · 2648574
  • Paroxetine Oral Product SCDG · 1164137
  • Paroxetine Pill SCDG · 1164138
  • Paroxetine hydrochloride Oral Product SCDGP · 2662815
  • Paroxetine hydrochloride Pill SCDGP · 2663638

Brand-Name Concepts

  • Paroxetine hydrochloride 25 MG [Paxil] SBDC · 1738500
  • Paroxetine Extended Release Oral Tablet [Paxil] SBDF · 828445
  • Paroxetine hydrochloride Extended Release Oral Tablet [Paxil] SBDFP · 2657455
  • Paxil Oral Product SBDG · 1182921
  • Paxil Pill SBDG · 1182922
  • Paxil BN · 114228

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1738806 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
60505-4377-03 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-... PAXIL CR Apotex Corp 2011-01-01
60505-4378-03 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-... PAXIL CR Apotex Corp 2011-01-01
60505-4379-03 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-... PAXIL CR Apotex Corp 2011-01-01
Observed labelers: Apotex Corp (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.